Urinary Incontinence affects over 83 million Women across Major Markets Says New Report

Piribo, the online destination for Pharma intelligence, has added a new report.
By: Joe Walsh
 
Dec. 21, 2010 - PRLog -- According to the report “Pipeline and Commercial Insight: Urinary Incontinence” available at http://www.piribo.com/publications/diseases_conditions/management_urinary_incontinence_overactive_bladder.html the urinary incontinence drug market has been displaying strong growth from 2005-09 owing to the uptake of new products driven by large marketing campaigns. Promotional efforts will remain integral to the success of new products entering this competitive market, ideally offering alternative mechanisms of action and potentially improved tolerability.

Urinary incontinence affects over 83 million women across the seven major markets. Anticholinergics form the mainstay of drug treatment yet side effects of dry mouth and constipation often cause patients to discontinue their medication. As such, efficacious drugs with new modes of action and fewer side effects will be well received in the market.

While competition in the anticholinergic class is fierce, there is an opportunity for companies with large commercial resources to develop the market further due to the high unmet need and the large patient population. As Pfizer turns its focus elsewhere, Astellas will become the leading company in the urinary incontinence market in 2019.

Opportunities exist in targeting niche populations as the sales and marketing spend required to market products populations will be lower, allowing specialist companies to define and own a segment of the market with reduced competition. One such example is Allergan with Botox (botulinum toxin A) in development for neurogenic bladder.

The report “Pipeline and Commercial Insight: Urinary Incontinence” is available from Piribo at:
http://www.piribo.com/publications/diseases_conditions/ma...

Piribo product ID: DAT09502

About Piribo

Piribo http://www.piribo.com/publications/diseases_conditions/in... is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.
End
Source:Joe Walsh
Email:***@piribo.com Email Verified
Zip:SE1 3LJ
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Piribo PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share